AI assistant
Sending…
PROKIDNEY CORP. — Director's Dealing 2024
Mar 5, 2024
32485_dirs_2024-03-05_67a8a531-e91c-4dc8-8375-79d49a1a80c3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PROKIDNEY CORP. (PROK)
CIK: 0001850270
Period of Report: 2024-03-01
Reporting Person: Girolamo Todd C (N/A)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-03-01 | Employee stock option (right to buy) | $1.61 | A | 300000 | Acquired | 2034-03-01 | Class A Ordinary Shares (300000) | Direct |
| 2024-03-01 | Employee stock option (right to buy) | $1.61 | A | 234742 | Acquired | 2034-03-01 | Class A Ordinary Shares (234742) | Direct |
Footnotes
F1: The option vests in substantially equal monthly installments over the four year period beginning on March 1, 2024.
F2: The option vests 50% on the 1st anniversary of March 1, 2024 and the remaining 50% vests in substantially equal monthly installments for 12 months thereafter.
More from PROKIDNEY CORP.
Regulatory Filings
2026
May 29
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 15
Annual Report
2026
Apr 17
Regulatory Filings
2026
Mar 18
Regulatory Filings
2026
Mar 18
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3